Iron-based Fe-Mn-Al-Ni shape-memory alloys are of rather low materials cost and show remarkable pseudoelastic properties. To further understand the martensitic transformation giving rise to the pseudoelastic properties, different Fe-Mn-Al-Ni alloys have been heat treated at 1473 K and quenched in ice water. The martensite, which is formed from a body-centred cubic austenite, is commonly described as face-centered cubic (f.c.c.), even though there are also more complex, polytypical descriptions of martensite. The presently studied backscatter Kikuchi diffraction (BKD) patterns have been evaluated, showing a structure more complex than simple f.c.c. This structure can be described by nanoscale twins, diffracting simultaneously in the exciting volume. The twinned structure shows a tetragonal distortion, not uncommon for martensite in spite of the lack of interstitial elements. These features are evaluated by comparing the measured BKD patterns with dynamically simulated ones.Energy-dispersive diffraction under both laboratory and synchrotron conditions was applied to study the hoop stress in the near-surface region of the inner wall of boreholes with a small diameter of 2 mm. By use of different X-ray beam cross sections for the sin2ψ measurements, it is demonstrated that the borehole-to-beam-diameter ratio must be considered in the evaluation. A beam cross section which is comparable to the borehole diameter reduces the slope of the d hkl φψ-sin2ψ distributions and thus invalidates the result of stress analysis. A quantitative relationship is applied, which allows the results obtained under the above conditions to be scaled so that they reflect the actual residual stress state at the measurement position. Owing to the small diffraction angles, energy-dispersive diffraction proves to be the only suitable experimental technique that allows a nondestructive and depth-resolved analysis of the hoop stress component at the inner surface of boreholes with a large length-to-diameter ratio.Two evaluation concepts for nondestructive depth-resolved X-ray residual stress analysis in the near-surface region of materials with cubic symmetry and nearly single crystalline structure are introduced by simulated examples. Both concepts are based on the same data acquisition strategy, which consists in the determination of lattice-spacing depth profiles along the 〈hkl〉 poles by stepwise sample rotation around the scattering vector. Segmentation of these profiles parallel to the sample surface provides the lattice strain state as a function of depth.  https://www.selleckchem.com/products/SRT1720.html  The first evaluation concept extends the crystallite group method developed for materials with pronounced crystallographic texture by the feature of depth resolution and can be applied to samples with arbitrary orientation. The second evaluation concept, which adapts the linear regression approach of the sin2ψ method for the case of single crystalline materials, is restricted to samples with (001) orientation. The influence of the strain-free lattice parameter a 0 on residual stress analysis using both evaluation concepts is discussed on the basis of explicitly derived relations.The science of X-ray free-electron lasers (XFELs) critically depends on the performance of the X-ray laser and on the quality of the samples placed into the X-ray beam. The stability of biological samples is limited and key biomolecular transformations occur on short timescales. Experiments in biology require a support laboratory in the immediate vicinity of the beamlines. The XBI BioLab of the European XFEL (XBI denotes XFEL Biology Infrastructure) is an integrated user facility connected to the beamlines for supporting a wide range of biological experiments. The laboratory was financed and built by a collaboration between the European XFEL and the XBI User Consortium, whose members come from Finland, Germany, the Slovak Republic, Sweden and the USA, with observers from Denmark and the Russian Federation. Arranged around a central wet laboratory, the XBI BioLab provides facilities for sample preparation and scoring, laboratories for growing prokaryotic and eukaryotic cells, a Bio Safety Level 2 laboratory, sample purification and characterization facilities, a crystallization laboratory, an anaerobic laboratory, an aerosol laboratory, a vacuum laboratory for injector tests, and laboratories for optical microscopy, atomic force microscopy and electron microscopy. Here, an overview of the XBI facility is given and some of the results of the first user experiments are highlighted.A recent article by Von Dreele, Clarke & Walsh [J. Appl. Cryst. (2021), 54, https//doi.org/10.1107/S1600576720014624] introduces an entirely new paradigm in structure determination, where a complete structural measurement is made in a tenth of a nanosecond.Diphenhydramine (Benadryl) is a first-generation antihistamine that is used primarily to treat allergic reactions including anaphylaxis, urticaria, and allergic rhinitis. Despite its availability as an over-the-counter medication, toxicity may occur with its use especially when administered in large doses or via the intravenous route. We present a 3-month-old infant with Trisomy 21 who suffered a cardiac arrest immediately following administration of a single 1.25 mg/kg dose of intravenous diphenhydramine, prescribed for sedation in the Pediatric ICU setting. The potential cardiovascular and respiratory effects of diphenhydramine are presented, previous reports of life-threatening adverse effects reviewed, and options to limit these effects discussed.Biologic agents, including anti-immunoglobulin E (omalizumab) and anti-interleukin 5 (mepolizumab), target different mediators involved in the inflammatory process and may work synergistically to decrease symptoms in patients with severe asthma. Here we describe a 12-year-old female on 2 biologic agents, omalizumab and mepolizumab, to control severe persistent asthma. Omalizumab was started years earlier with an initial response; however, her asthma again became uncontrolled and mepolizumab was added. Both biologics were administered concomitantly for over 6 months with marked improvement of asthma symptoms without significant side effects. A combination of biologic agents may be a potential therapy for pediatric patients with severe persistent asthma that remains uncontrolled on a single agent.